Home › Therapeutic areas › Immunology › Dermatomyositis
Dermatomyositis (3 companies)
Companies with an active program in Dermatomyositis.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| CABA | Cabaletta Bio | DermatologyImmunology+2 Rare | 1 | Phase 2 | $280M | 8 |
| RNAC | Cartesian Therapeutics | ImmunologyNeurology+1 Rare | 1 | Phase 3 | $230M | 4 |
| JBIO | Jade Biosciences | ImmunologyRenal Rare | 1 | Phase 2 | $958M | 4 |
No companies match.